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ABSTRACT : Navayasa curna mixed in Lohasava was screened for hepatoprotective activity 
against carbon tetrachloride induced liver injury in albino rats at a dose of 100mg/kg body 
weight. The drug reduced liver weight, alkaline phosphatase and GOT activity in liver and 
chloresterol and GPT activity in serum.  There was no effect on protein and liver glycogen. 
 
INTRODUCTION  
 
Many of the metabolic activities of the body 
are centered in the liver.  The liver 
undergoes rapid changes in size and in 
glycogen and protein content depending 
upon nutritional state.  But a damaged liver 
invariably shows increased alkaline phos-
phatase and glutamate pyruvic transaminase 
(GPT) and glutamate ox-aloacetic (GOT) 
transaminase, A similar response may 
follow exposure to various chemicals and 
drugs, generally damage in liver takes place 
due to environmental factors, chemicals, 
drugs and contaminated food. 
 
There are a number of herbs and 
formulations in the Indian system of 
medicine to repair liver damage, Lohasava 
and Navayasa curna are two such Ayurvedic 
drugs.  In south India they are prescribed in 
comibation to treat a wide variety of Liver 
disease, these two drugs are screened against 
carbon tetrachloride in- duced liver injury in 
albino rats(1). 
 
Materials and Methods 
 
Navayasa curna and Lohasava were 
prepared in our pharmacy. Navayasa curna 
as suspended in Lohasava at a concentration 
of 2 g/30ml. these drugs were administered 
orally at a dose of 100mg/kg body weight. 
 
Male albino rats weighing 180 -200g from 
the Institute’s animal house were used for 
the study.  There were three groups each 
consisting of seven rats.  The first group 
served as control and received appropriate 
quantity of olive oil subcutane-ously on the 
second and third day. The second group 
received carbon tetrachloride mixed in olive 
oil (1:1) a dose of 2 ml /kg body weight on 
second and third day.  The third group 
received Navayasa curna mixed in Lohasava 
at a dose of 100 mg/kg body weight on all 
the four days. Carbon tetrachloride was 
administered on second and third day.  The 
animals were maintained on Hindustan level 
rat feed, bengal gram and cabbage and water 
as libitum. All the animals were sacrificed 
on the fifty day and   blood was drawn 
through glass syring by punturing the heart 
and serum was separated.  The wet weight 
of liver was recorded and 10 % liver 
homogenate was prepared in cold double 
distilled water, serum and liver homogenate 
were used for the determination of GPT, 
GOT(2) protein(3) and alkaline phos-
phatase (4). Glycogen (5) and cholesterol (6) Pages 332-336 
were determined in liver and serum 
respectively. Students ‘t’ test was applied to 
analyse the results. 
 
Results and Discussion: 
 
The tested medicine protected the liver from 
carbon tetra-chloride induced injury. A 
significant reduction in the alkaline 
phosphatase activity was caused by the 
tested drug in both liver and serum (Table 1 
& 2). Lohasava containing Navayasa curna 
reduced the liver weight and GOT activity in 
liver. Serum showed significant reduction in 
the alkaline phosphatase and GPT activities 
(Table 2).  Serum cholesterol was also 
significantly reduced.  The tested drugs did 
not affect liver and serum proteins and liver 
glycogen significantly. 
 
The mechanism of carbon tetrachioride liver 
injury is through the production of toxic 
trichloro methyl freel radicals (CC13) by the 
liver microsomes during the metablolism of 
carbon tetrachloride (CC14) the free radical 
is highly reactive and binds co-valently to 
proteins and lipids with the initiation   of  
endoplasmic reticulum leading to cell 
necrosis (7-19).  Since the tested drugs have 
reduced the activity of alkaline phosphatase, 
GPT and GOT, it can be assumed that the 
leakage of enzymes is effectively controlled 
and that the integrity of cellular membrane 
is maintained. 
 
Phyllanthus emblica and  curcuma longa 
present in lohasava and navayasa curna are 
reported to possess antihepatotoxic 
propertieis. Gulati et al (11) have observed 
that the biflavanoid present in P. emblica 
prevents cytotoxicity in isolated hepatocytes 
caused by carbon tetrachloride and tertiary 
butyl hydorperoxide.  There is also the 
report of using fruits of P.emblica  in 
combination with iron in jaundice (gulati et 
al (11) Kiso et al  (12) found that 
antihepatotoxic effect of curcuma longa
 
 
against carbon tetrachloride induced liver 
damage was due to curmcuminoids and that 
some analogues of ferulic acid and P 
coumaric acid, probable metabolites of 
curcuminods, also have liver protective 
activity. 
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Table -1 
Effect of Navayasa curna in Lohasava on Liver biochemical parameters 
(Values are mean ± SD) 
 
Group  Liver weight g/100g 
body weight 
Glycogen 
g/100g 
Protein mg/g  Alkaline
l 
phosphatase 
GPT 
2  GOT 
3 
Normal  3.134 ± 0.144  1.85 ± 0.172  100.0 ± 10.5  0.0030 ± 
0.0004 
0.5879 ± 
0.097 
0.1968±  
0.041 
Carbon 
tetrachloride 
3.670 ± 0.025  1.56 ± 0.147  119.0 ± 20.2  0.0108 ± 
0.00093 
0.5903 ± 
0.128 
0.4966 ± 
0.069 
Navayasa 
curna in 
Lohasava 
3.400
a ± 0.096  1.631 ± 0.134  101.0 ± 8.27  0.0042
b± 
0.00014 
0.5615 ± 
0.114 
0.4245
a±  
0.004 
 
1.  Expressed as mg phenol liberated /mg protein in 15min at 37
oC. 
2.  Expressed as mg Pyruvate /mg protein in 30min at 37
oC. 
3.  Expressed as mg Pyruvate /mg protein in 60min at 37
oC. 
Values are significant when P<0.05 
P values a:p<0.05, b:p<0.001 
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Table -2 
Effect of Navayasa curna in Lohasava on serum biochemical parameters 
(Values are mean ± SD) 
 
Group  Protein mg/g  Alkaline
l 
phosphatase 
GPT 
2  GOT 
3  Cholesterol 
mg/100ml 
Normal  10266 ± 1331  32.65 ± 6.32  14.33 ± 9.01  8.2 ± 0.645  16.62 ± 
0.197 
Carbon 
tetrachloride 
10350 ± 1515  47.62 ± 2.56  56.5 ± 2.12  26.25±  2.98  22.0 ± 3.69 
Navayasa 
curna in 
Lohasava 
8840 ± 1023  23.66 ± 3.26
b  25.4 ± 0.18
b  24.0 ± 3.9  16.3 ± 0.30
a 
 
1  Expressed as mg phenol liberated /100ml Serum in 15min at 37
oC. 
2  Expressed as mg Pyruvate liberated /100ml Serum in 30min at 37
oC. 
3  Expressed as mg Pyruvate liberated /100ml Serum in 60min at 37
oC. 
           Values are significant when P<0.05 
P values a:p<0.05, b:p<0.001 
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There are 10 and 15 raw drugs in the 
formulations of Navayasa curna and 
Lohasava respectively (Anonymous) (13).   
All the ingredients of Navayasa curna are 
present in  Lohasava.  In Navayasa curna 
Agoraja (Lohabasma) is used whereas in 
Lohasava, loha curna (iron filings) is used. 
 
Navayasa curna is prescribed in Pandu, 
Kamala, Prameha Pidaka and hydroga, 
while Lohasava is given in Pandu, Jathara, 
gulma, svayathu and arasa 913).  As per the 
literature, both the medicines are presecribed 
for ailments pertaining to liver. 
The  study reveals that Navayasa curna 
mixed in Lohasava has the potential to 
prevent carbon tetrachloride induced liver 
damage. 
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